Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
NEW YORK (Reuters Health) – A closed-loop hydration and fluid balancing system protects against contrast-induced acute kidney injury in high-risk patients, according to results of a study published…
NEW YORK (Reuters Health) – Among patients undergoing cardiac procedures, a lower dose of contrast medium based on calculated creatinine clearance may reduce the risk of contrast-induced nephropathy,…
NEW YORK (Reuters Health) – A short course of methylprednisolone added to antibiotic therapy for acute pyelonephritis in children significantly reduces the development of renal scars, a Taiwanese…
NEW YORK (Reuters Health) – Perioperative treatment with low-dose human atrial natriuretic peptide (carperitide) improves outcomes in patients with chronic kidney disease (CKD) who are undergoing coronary artery…
NEW YORK (Reuters Health) – Pooled data suggest that cancer patients who are treated with sunitinib (Sutent; Pfizer) have about a 2-fold increased relative risk of developing high-grade…
NEW YORK (Reuters Health) – Kidney failure during hemolytic uremic syndrome is less likely to develop in children with diarrhea due to virulent E. coli infection if they’re…
NEW YORK (Reuters Health) – When performed at centers of excellence, robotic partial nephrectomy (RPN) has “an acceptably low” complication rate that mirrors that of open partial nephrectomy…
NEW YORK (Reuters Health) – Ambulatory blood pressure monitoring (ABPM) is a better predictor of renal and cardiovascular events than office BP measurement in patients with chronic kidney…
NEW YORK (Reuters Health) – While angiotensin receptor blockers (ARBs) as a class do not appear to be associated with an increased malignancy risk in patients with diabetes,…
NEW YORK (Reuters Health) – Some patients with metastatic clear-cell renal cancer appear to fare relatively well when treated with sunitinib before undergoing planned nephrectomy — even though…
